The Public Health Commission, in which the Ministry of Health and the autonomous communities are represented, has endorsed the booster dose of the vaccine against Covid-19 for people between 59 and 40 years old, starting with the oldest.
As reported by the Ministry of Health, this booster dose will be administered 6 months after the last dose with mRNA, following the recommendations of the Vaccine Report.
Likewise, it has also been approved to administer booster doses to those under the age of 60 who received AstraZeneca, mainly essential workers, such as teachers, firefighters or police officers. In these people, the booster dose will be given 3 months after the last dose.
On the other hand, the Public Health Commission has insisted that vaccination should be prioritised in people 12 years of age and in those people who have not yet received any dose of the vaccine and booster doses in the most vulnerable groups, that is, those over 60 years old.
In addition, they recalled that people of any age who received a dose of Janssen vaccine should also receive a booster dose, as already stated in the Vaccination Strategy.
The Minister of Health, Carolina Darias, reported yesterday at a press conference, after the Interterritorial Council of the National Health System (CISNS), that more than 81 million doses of vaccines against covid-19 have already been administered, and the coverage with the complete guideline is 89.6 percent for the target population, over 11 years of age.
Regarding booster doses, 80 percent of those over 70 have received their third vaccination, as have 46 percent of those over 60 and 49 percent of those who received the Janssen single-dose. In the case of people between 60 and 69 years old, Spain has a 46 percent coverage in third doses.
The measure to vaccinate everyone over 40 is in line with what was demanded by the president of the European Commission, Ursula von der Leyen, a few weeks ago to stop the rise in infections throughout Europe.
Furthermore, several studies have pointed out that two doses may not be sufficient to effectively protect the population against the new omicron variant, thus having to administer a booster dose.
